LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 497
Next
>>
>
1 to 25 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
Hs 578T	AZD 5438	0.04	uM	LJP6	3	J06	72	hr	658	3195	3846	0.8307	0.7958
Hs 578T	AZD8055	0.04	uM	LJP6	2	A12	72	hr	658	1155	3846	0.3003	0.1558
Hs 578T	Alvocidib	0.04	uM	LJP6	1	A18	72	hr	658	1126	3846	0.2928	0.1468
Hs 578T	AZD 5438	0.04	uM	LJP6	2	J06	72	hr	658	3390	3846	0.8814	0.8569
Hs 578T	AZD7762	0.04	uM	LJP6	1	L06	72	hr	658	2050	3846	0.5330	0.4366
Hs 578T	AZD8055	0.04	uM	LJP6	1	A12	72	hr	658	1226	3846	0.3188	0.1781
Hs 578T	Afatinib	0.04	uM	LJP6	3	G24	72	hr	658	3476	3846	0.9038	0.8839
Hs 578T	Sigma A6730	0.04	uM	LJP5	3	B24	72	hr	658	3839	3846	0.9982	0.9978
Hs 578T	AT-7519	0.04	uM	LJP6	1	K06	72	hr	658	2657	3846	0.6908	0.6270
Hs 578T	AZD 5438	0.04	uM	LJP6	1	J06	72	hr	658	2991	3846	0.7777	0.7318
Hs 578T	AZD-6482	0.04	uM	LJP5	2	I06	72	hr	658	3878	3846	1.0083	1.0100
Hs 578T	AZD-6482	0.04	uM	LJP5	3	I06	72	hr	658	3687	3846	0.9586	0.9501
Hs 578T	AZD7762	0.04	uM	LJP6	2	L06	72	hr	658	2178	3846	0.5663	0.4767
Hs 578T	AZD7762	0.04	uM	LJP6	3	L06	72	hr	658	2165	3846	0.5629	0.4727
Hs 578T	Afatinib	0.04	uM	LJP6	1	G24	72	hr	658	3551	3846	0.9233	0.9074
Hs 578T	Afatinib	0.04	uM	LJP6	2	G24	72	hr	658	3643	3846	0.9472	0.9363
Hs 578T	Sigma A6730	0.04	uM	LJP5	1	B24	72	hr	658	3740	3846	0.9724	0.9667
Hs 578T	Sigma A6730	0.04	uM	LJP5	2	B24	72	hr	658	3777	3846	0.9820	0.9783
Hs 578T	Alvocidib	0.04	uM	LJP6	2	A18	72	hr	658	1073	3846	0.2790	0.1301
Hs 578T	Alvocidib	0.04	uM	LJP6	3	A18	72	hr	658	1058	3846	0.2751	0.1254
Hs 578T	AT-7519	0.04	uM	LJP6	2	K06	72	hr	658	2964	3846	0.7707	0.7233
Hs 578T	AT-7519	0.04	uM	LJP6	3	K06	72	hr	658	2872	3846	0.7467	0.6944
Hs 578T	AZD-6482	0.04	uM	LJP5	1	I06	72	hr	658	3543	3846	0.9212	0.9049
Hs 578T	AZD8330	0.04	uM	LJP5	1	G24	72	hr	658	958	3846	0.2491	0.0940
Hs 578T	AZD8055	0.04	uM	LJP6	3	A12	72	hr	658	1219	3846	0.3169	0.1759

<
<<
Previous
Page 1 of 497
Next
>>
>
1 to 25 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)